- Home
- MNMD
MNMD
Mind Medicine (MindMed) Inc.
as 05-09-2025 3:39pm EST
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $25.75 | AVG Volume (30 days): | 852.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.70 - $10.44 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Mind Medicine (MindMed) Inc. (MNMD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sullivan Mark | MNMD | Chief Legal Officer | Mar 25 '25 | Sell | $6.74 | 6,576 | $44,322.24 | 316,621 | |
| Barrow Robert | MNMD | Chief Executive Officer | Mar 25 '25 | Sell | $6.74 | 21,208 | $142,941.92 | 856,556 | |
| Karlin Dan | MNMD | Chief Medical Officer | Mar 25 '25 | Sell | $6.74 | 6,836 | $46,074.64 | 446,177 | |
| Liao Carrie | MNMD | Chief Accounting Officer | Mar 25 '25 | Sell | $6.74 | 2,347 | $15,818.78 | 144,923 |
Latest Mind Medicine (MindMed) Inc. News
MNMD Breaking Stock News: Dive into MNMD Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates
Business Wire
15 days ago
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025
Simply Wall St.
16 days ago
Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Business Wire
18 days ago
MindMed Announces New Employee Inducement Grants
Business Wire
24 days ago
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
Business Wire
a month ago
MindMed Announces New Employee Inducement Grants
TipRanks
2 months ago
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
TipRanks
2 months ago
Psychedelic: atai Life Sciences, NRx report quarterly results
Compare MNMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MNMD Mind Medicine (MindMed) Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.